Published in AIDS Weekly, November 11th, 2002
According to Dr. Hans J. Hansen, Immunomedics, who invented this new technology, "This patent covers multivalent antibodies that cross-link microorganisms and viruses to monocytes and macrophages - cells that can ingest and destroy the microorganisms. These cells, as well as dendritic cells that are also targeted, can process antigens from the microorganisms and 'educate' immune cells of patients so that they can expand in number and more effectively kill the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.